“Science is the backbone of these new blends. They were designed to give users a consistent and pleasant experience every time they are used,” said Dr. Russo. “They can be added to a wide range of products to enhance smell and encourage specific moodstates."
PORTLAND, Ore. (PRWEB) July 27, 2020
True Terpenes, the leading platform for terpenes innovation, research and development, has launched “Terpology by Dr. Ethan Russo,” an exclusive line of effect-based terpene blends. When combined with cannabis or CBD, infused in cosmetics or placed in a diffuser, these blends create a more balanced and pleasant experience and encourage users to be more focused, have more energy, or be more calm. Product images can be found here.
Terpenes are aromatic compounds found in many plants that provide aroma and flavor to various products, including food/beverage, cannabis, and beauty. These new effect-based blends were specifically designed by Dr. Russo to have a biochemical and pharmacological base and a pleasant smell.
“Terpology by Dr. Ethan Russo” is available in three effects:
- Focus: Based on a foundation of alpha pinene, a terpene found in pine needles and conifer that helps clear the head. When combined with linalool, a terpene found in lavender, it helps people calm down and focus.
- Energy: Using alpha pinene, to reduce short-term memory impairment, and limonene for mood elevation, this blend improves concentration.
- Calm: This blend features a mix of linalool and limonene. When working together, the calming agents in linalool and the mood-elevating effect of limonene, the main ingredient of citrus, causes relaxation.
“Science is the backbone of these new blends. They were designed to give users a consistent and pleasant experience every time they are used,” said Dr. Russo. “They can be added to a wide range of products to enhance smell and encourage specific moodstates. I look forward to continuing my work with True Terpenes, expanding the line and continuing to educate people about the benefits of terpenes.”
“Dr. Russo is at the forefront of terpene research and innovation, making him the ideal candidate to design an original product line for True Terpenes," said Chris Campagna, CEO of True Terpenes. “As a company, we are continuously looking for new and exciting ways to bring terpenes into people's lives, and these effects-based blends are the best way to introduce people to the world of terpenes.
Dr. Russo is a board-certified neurologist and a research pioneer in cannabis and psychopharmacology. His work has helped popularize the entourage effect, where the benefits of medical cannabis can be enhanced when combined with terpenes. He is also a member of the recently launched True Terpenes Scientific Advisory Board where he is working alongside pharmaceutical expert, Dr. Randall Murphy, to advance terpenes research.
“Terpology by Dr. Ethan Russo” effects-based terpene profiles are available today in a variety of sizes exclusively at http://TrueTerpenes.com.
About True Terpenes
True Terpenes, a fully owned subsidiary of True Companies, is the industry-leading producer of effects-based, GMP/ISO/FSSC-certified terpenes and terpenoids blends. Using ultra-refined botanical terpenes and other aromatic compounds, the custom terpene blends are used for beverage, cannabis, cosmetic, food, industrial and pharmaceutical products. The company uses advanced scientific analysis to identify terpenes and other compounds in the cannabis plant for recreation by utilizing other botanicals and hemp-derived ingredients. This allows companies in various industries looking to leverage cannabis flavors and effects with a scalable, standardized, and worldwide legal solution.
Any forward-looking statements included in this document are made as of the date of this document and Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Although management of the Corporation believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct.
Samantha Qualls, Senior Director